Information
-
Trademark
-
79168375
-
Serial Number
79168375
-
Registration Number
4872521
-
International Classifications
-
Filing Date
January 14, 2015
10 years ago
-
Registration Date
December 22, 2015
10 years ago
-
Transaction Date
May 09, 2023
2 years ago
-
Status Date
July 08, 2022
3 years ago
-
Published for Opposition Date
October 06, 2015
10 years ago
-
Location Date
December 22, 2015
10 years ago
-
Status Code
709
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
FLETCHER, TRACY L
-
Attorney Name
John Alumit
Law Office Assigned Location Code
M60
-
Owners
Mark Drawing Code
4000
Mark Identification
LYOPAN
Case File Statements
- GS0051: Almond oils for pharmaceutical purposes; Antibacterial pharmaceuticals; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of nutritional supplements and of pharmaceutical preparations; Homeopathic pharmaceuticals for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for skin care; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the treatment of joint disease; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, anti-infectives; Amino acids for medical or veterinary purposes; Anti-infective products for veterinary use; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Biochemical preparations, namely, reagents for medical and veterinary diagnostic purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Veterinary preparations, namely, pain relief medication; Veterinary preparations for treatment of intestinal bacteria; Veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in a variety of animal; Veterinary preparations, namely, antioxidants; veterinary vaccines; health care preparations, namely, dietary supplements; Dietetic foods adapted for medical use, namely, bread, cookies and crackers; Diet capsules, Diet pills, Food for medically restricted diets, namely, pasta, crackers and candy adapted for medical use; food for babies; medical plasters; medical dressings; material for dental fillings and dental impressions; all-purpose disinfectants; Gastrointestinal cleaning agents; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic candy; preparations for destroying vermin; fungicides; herbicides; nutritional supplements; pharmaceutical effervescent tablets for treating upset stomach and stomach disease; medicine delivery agents in the form of soft-gelatin capsules for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of powders for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of tablets for the controlled release of active ingredients for a wide range of pharmaceutical products
- GS0031: Dental bleaching gels, Tooth bleaching preparations, Laundry bleach, blueing, detergent, pre-soak, sizing, soap and starch; general purpose cleaning, polishing, degreasing and abrasive liquids and powders; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices; descaling agents and descaling agents in tablet form for household use; all-purpose cleaning preparations
- GS0011: Chemicals for use in industry and science; photographic chemicals; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; soil fertilizers; fire extinguishing compositions; tempering preparations; soldering chemicals; tempering chemicals for use in soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives for use in industry; descaling preparations and descaling preparations in tablet form for industrial purposes
- TR0010: The wording "LYOPAN" has no meaning in a foreign language.
Case File Event Statements
-
5/9/2023 - 2 years ago
46 - TOTAL INVALIDATION PROCESSED BY THE IB
Type: INNT
-
4/20/2023 - 2 years ago
45 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Type: INTS
-
4/20/2023 - 2 years ago
44 - INVALIDATION PROCESSED
Type: INPC
-
3/8/2023 - 2 years ago
43 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Type: INTR
-
7/8/2022 - 3 years ago
42 - CANCELLED SECTION 71
Type: C71T
-
12/22/2020 - 5 years ago
41 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Type: REM3
-
7/15/2016 - 9 years ago
40 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
4/11/2016 - 9 years ago
39 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
4/11/2016 - 9 years ago
38 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
3/22/2016 - 9 years ago
37 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
2/22/2016 - 9 years ago
36 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Type: CORN
-
2/12/2016 - 9 years ago
35 - CORRECTION TRANSACTION RECEIVED FROM IB
Type: CRCV
-
12/22/2015 - 10 years ago
34 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
10/6/2015 - 10 years ago
33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
10/6/2015 - 10 years ago
32 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/2/2015 - 10 years ago
31 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
9/16/2015 - 10 years ago
30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
9/16/2015 - 10 years ago
29 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
9/16/2015 - 10 years ago
28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
9/1/2015 - 10 years ago
27 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
8/28/2015 - 10 years ago
26 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
8/28/2015 - 10 years ago
25 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/28/2015 - 10 years ago
24 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/28/2015 - 10 years ago
23 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
8/27/2015 - 10 years ago
22 - NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Type: RDX3
-
8/27/2015 - 10 years ago
21 - ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Type: RDX1
-
8/27/2015 - 10 years ago
20 - ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Type: RRDX
-
8/27/2015 - 10 years ago
19 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/26/2015 - 10 years ago
18 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/26/2015 - 10 years ago
17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
8/5/2015 - 10 years ago
16 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
8/5/2015 - 10 years ago
15 - FINAL REFUSAL E-MAILED
Type: GNFR
-
8/5/2015 - 10 years ago
14 - FINAL REFUSAL WRITTEN
Type: CNFR
-
8/5/2015 - 10 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/5/2015 - 10 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/1/2015 - 10 years ago
11 - REFUSAL PROCESSED BY IB
Type: RFNT
-
7/28/2015 - 10 years ago
10 - ASSIGNED TO LIE
Type: ALIE
-
7/19/2015 - 10 years ago
9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/14/2015 - 10 years ago
8 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
7/13/2015 - 10 years ago
7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
7/13/2015 - 10 years ago
6 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
7/12/2015 - 10 years ago
5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
7/11/2015 - 10 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
7/10/2015 - 10 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
7/10/2015 - 10 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
7/9/2015 - 10 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR